义翘神州 (301047.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 13.42B

MomentumView details →

1D Return

−7.13%

YTD Return

+36.01%

RSI (14)

43.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 13.42B

RSI (14)

43.8

MomentumView details →

1D Return

−7.13%

YTD Return

+36.01%

ProfitabilityView details →

Gross Margin

73.66%

Net Margin

21.61%

EBITDA Margin

35.06%

ROE (TTM)

2.95%

ROA (TTM)

2.83%

Asset Turnover

0.13x

GrowthView details →

Revenue YoY

+18.01%

EPS YoY

+62.20%

FCF YoY

+31.46%

Revenue CAGR 3Y

+6.78%

EPS CAGR 3Y

−22.99%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

26.66x

Quick Ratio

26.06x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

727.69M

Net Income (TTM)

157.25M

Op. CF (TTM)

176.81M

Latest newsMore news →

Yiqiao Shenzhou announced the launch of recombinant human full-length, tag-free p-Tau217 protein for the development of Alzheimer's disease biomarker detection.32d ago

Similar companies

百普赛斯301080.SZ 药石科技300725.SZ 广电计量002967.SZ 华大基因300676.SZ 深城交301091.SZ 信测标准300938.SZ

Latest newsMore news →

Yiqiao Shenzhou announced the launch of recombinant human full-length, tag-free p-Tau217 protein for the development of Alzheimer's disease biomarker detection.32d ago